SyntheticGestalt

About:

SyntheticGestalt develops machine learning models for drug discovery and software for facilitating and automating research.

Website: https://www.syntheticgestalt.com/

Twitter/X: sgestalt_uk

Top Investors: Incubate Fund, MITSUI SUMITOMO INSURANCE Venture Capital (MSIVC), Headline Asia (formerly Infinity Ventures), The Future Fund

Description:

SyntheticGestalt creates tools and methods for applied machine learning-based drug discovery that are aimed at streamlining and automating research in the life sciences sector. The company's synthetic biology simulation models can accurately predict the outcomes of various amino acid arrangements without having to perform time-consuming experimental steps, helping pharmaceutical companies by automating and accelerating the drug development process. Preclinical candidates are chemical compounds discovered through research that have the potential to become new drugs for the treatment of a particular disease.